Iovance Biotherapeutics, Inc. IOVA Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $46.78M.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s total debt?
- Iovance Biotherapeutics, Inc. (IOVA) reported total debt of $46.78M in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s total debt changed year-over-year?
- Iovance Biotherapeutics, Inc.'s total debt decreased by 11.3% year-over-year, from $52.72M to $46.78M.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s total debt?
- Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s total debt has grown at a -1.3% compound annual growth rate (CAGR), from $51.66M to $48.44M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.